Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520)

NCT01852812 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

87

Enrollment

INDUSTRY

Sponsor class

Conditions

Perennial Allergic Rhinitis

Interventions

DRUG: Montelukast Oral Granules (OG)
DRUG: Montelukast Chewable Tablets (CT)

Sponsor

Organon and Co